Meta-Analysis and Subgroups

被引:0
|
作者
Michael Borenstein
Julian P. T. Higgins
机构
[1] Biostat,School of Social and Community Medicine
[2] Inc,Center for Reviews and Dissemination
[3] University of Bristol,undefined
[4] University of York,undefined
来源
Prevention Science | 2013年 / 14卷
关键词
Meta-analysis; Research synthesis; Systematic review; Subgroups; Subgroup analysis; Fixed-effect; Fixed-effects; Random-effects;
D O I
暂无
中图分类号
学科分类号
摘要
Subgroup analysis is the process of comparing a treatment effect for two or more variants of an intervention—to ask, for example, if an intervention’s impact is affected by the setting (school versus community), by the delivery agent (outside facilitator versus regular classroom teacher), by the quality of delivery, or if the long-term effect differs from the short-term effect. While large-scale studies often employ subgroup analyses, these analyses cannot generally be performed for small-scale studies, since these typically include a homogeneous population and only one variant of the intervention. This limitation can be bypassed by using meta-analysis. Meta-analysis allows the researcher to compare the treatment effect in different subgroups, even if these subgroups appear in separate studies. We discuss several statistical issues related to this procedure, including the selection of a statistical model and statistical power for the comparison. To illustrate these points, we use the example of a meta-analysis of obesity prevention.
引用
收藏
页码:134 / 143
页数:9
相关论文
共 50 条
  • [21] Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials
    Signori, A.
    Schiavetti, I.
    Gallo, F.
    Sormani, M. P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (06) : 960 - 966
  • [22] Bayesian sparse modeling to identify high-risk subgroups in meta-analysis of safety data
    Qi, Xinyue
    Zhou, Shouhao
    Wang, Yucai
    Peterson, Christine
    [J]. RESEARCH SYNTHESIS METHODS, 2022, 13 (06) : 807 - 820
  • [23] Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups
    Qi, Wei-Xiang
    Shen, Zan
    Tang, Li-Na
    Yao, Yang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (08) : 893 - 906
  • [24] Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups
    Wei-Xiang Qi
    Zan Shen
    Li-Na Tang
    Yang Yao
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 893 - 906
  • [25] Meta-analysis
    Yusuf, S
    Pogue, J
    [J]. LANCET, 1998, 351 (9120): : 1960 - 1960
  • [26] Meta-analysis
    Hagger, Martin
    [J]. INTERNATIONAL REVIEW OF SPORT AND EXERCISE PSYCHOLOGY, 2022, 15 (01) : 120 - 151
  • [27] The meta-analysis
    Quintanilha Ribeiro, Fernando de Andrade
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2017, 83 (05) : 497 - 497
  • [28] Meta-analysis
    Rosendaal, F. R.
    Reitsma, P. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) : 1009 - 1009
  • [29] Meta-analysis
    DeMaria, Anthony N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (03) : 237 - 238
  • [30] META-ANALYSIS
    BULPITT, CJ
    [J]. LANCET, 1988, 2 (8602): : 93 - 94